Krystal Biotech, Inc. (BIT:1KRYS)
Italy
· Delayed Price · Currency is EUR 124.00
-21.20 (-14.60%)
At close: May 6, 2025
Krystal Biotech Revenue
Krystal Biotech had revenue of $88.18M USD in the quarter ending March 31, 2025, with 94.88% growth. This brings the company's revenue in the last twelve months to $333.45M, up 247.53% year-over-year. In the year 2024, Krystal Biotech had annual revenue of $290.52M with 473.02% growth.
Revenue (ttm)
$333.45M
Revenue Growth
+247.53%
P/S Ratio
11.75
Revenue / Employee
$1.21M
Employees
275
Market Cap
3.62B EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Intesa Sanpaolo | 25.42B |
| UniCredit | 23.99B |
| Enel SpA | 78.35B |
| Ferrari | 6.88B |
| Assicurazioni Generali | 55.30B |
| Eni S.p.A. | 90.96B |
| Leonardo S.p.a. | 18.26B |
| Stellantis | 156.88B |